Rare diseases
Investigational molecules
Locations
Baumleingasse 22, 4051
Clinical research activity is centered on Parkinson's disease, with interest in therapies that support symptom management through transdermal delivery approaches. The current trial focus reflects evaluation of a rotigotine patch in people living with this neurological disorder.
Research attention is directed toward treatment delivery features relevant to motor symptom care in Parkinson's disease, with a specific emphasis on patch performance in clinical use.
Luye Pharma Switzerland AG runs clinical trials in conditions such as Parkinson's disease, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
